Indy maker of dental analytics software sold to Atlanta company
The sale to True Nature Holding Inc. is expected to close by October. Neither party would say whether the Indianapolis operations would remain here.
The sale to True Nature Holding Inc. is expected to close by October. Neither party would say whether the Indianapolis operations would remain here.
An estimated 85,000 low-income Hoosiers who receive Medicaid benefits will soon need to find a job, volunteer, get job training, or go to school—or risk losing health care for a few months.
The Indianapolis medical-software firm recently raised $10 million in venture funding and is launching two major products in one month.
The hospital system said the facility would help meet the soaring demand for hip and knee replacements while also serving patients with the “most complex” orthopedic conditions.
The lawsuit by a former medical director alleges St. Vincent engaged in a practice of “pushing out employees over the age of 40 and hiring substantially younger employees.”
The “Roche Academy” will provide mentors, internships and special curriculum to biology and chemistry undergrads, along with financial incentives and a job offer after graduation.
The Indianapolis-based drugmaker has appealed its annual tax bill for its two massive campuses south of downtown every year since 2012.
Overdose deaths in Indiana rose 18 percent last year compared with 2016 and 37 percent over 2015. A vast majority of the overdoses were caused by opioids.
The Indiana Medical Licensing Board voted to prohibit the 79-year-old Donald Cline from ever applying for a license in Indiana again.
During the past 20 years, Riley Children’s Foundation has raised $500 million, the majority of which has been spent for pediatric research and patient programs at Riley Hospital.
Peppy Grill, 1004 Virginia Ave., has been closed by the Marion County Health Department after an inspector found food was not being stored at proper temperatures.
Insurance companies say it will take time to design new plans and get approval from state regulators.
The American Medical Association recently called on regulators to monitor competition among the three drugmakers who control the market—Indianapolis-based Eli Lilly and Co., Denmark-based Novo Nordisk and Paris-based Sanofi.
After decades of being starved of innovative treatments for serious conditions like cancer, diabetes and kidney disease, China’s 1.4 billion people are becoming a prime target for Eli Lilly and other pharmaceutical companies.
The university said it has hired 33 research faculty to help under the “Grand Challenges” program in precision health, an initiative it rolled out two years ago.
The run-up in share price seems to reflect investor sentiment that the Indianapolis drugmaker has turned a corner after more than a decade of struggling to launch new medicines.
The Trump administration is preparing a regulation that would allow the resumption of billions of dollars in payments to health insurers in Obamacare, a development welcomed by Indianapolis-based Anthem Inc.
The case might never have come to light were it not for a nearly century-old Indianapolis company that had a chance to participate in the overbilling and kickback scheme but called the FBI instead.
Indiana University Health's chief health information officer has a passion for languages.
The Pendleton Council approved the project Thursday night, along with a $3.2 million incentive package to help encourage the development.